Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 197
Gene Symbol: AHSG
AHSG
0.300 Biomarker disease CTD_human Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. 16177000 2005
Entrez Id: 249
Gene Symbol: ALPL
ALPL
0.300 Biomarker disease CTD_human Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats. 21193197 2011
Entrez Id: 632
Gene Symbol: BGLAP
BGLAP
0.300 Biomarker disease CTD_human Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. 21335463 2011
Entrez Id: 729
Gene Symbol: C6
C6
0.300 Biomarker disease CTD_human Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. 21335463 2011
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.300 Biomarker disease CTD_human Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. 21335463 2011
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.300 Biomarker disease CTD_human Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. 21335463 2011
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.300 Biomarker disease CTD_human Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats. 21193197 2011
Entrez Id: 80781
Gene Symbol: COL18A1
COL18A1
0.300 Biomarker disease CTD_human Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. 21335463 2011
Entrez Id: 1277
Gene Symbol: COL1A1
COL1A1
0.300 Biomarker disease CTD_human Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. 21335463 2011
Entrez Id: 80169
Gene Symbol: CTC1
CTC1
0.300 Biomarker disease CTD_human Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. 22267198 2012
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.300 Biomarker disease CTD_human Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. 18340010 2008
Entrez Id: 2056
Gene Symbol: EPO
EPO
0.300 Biomarker disease CTD_human We present a dialysis patient who developed tumoral calcinosis over the right shoulder after receiving a misplaced injection of human recombinant erythropoietin probably into the periarticular tissue. 12148126 2002
Entrez Id: 2209
Gene Symbol: FCGR1A
FCGR1A
0.300 Biomarker disease CTD_human Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure. 21335463 2011
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 Biomarker disease BEFREE In summary, we have detected novel GALNT3 mutations that result in familial TC, and show that disturbed serum FGF23 concentrations are present in our TC cases as well as in previously reported cases. 17853462 2007
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 GeneticVariation disease BEFREE Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. 25378588 2014
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 Biomarker disease BEFREE The objective of the study was to analyze the involvement of FGF23 in the development of tumoral calcinosis. 16030159 2005
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 Biomarker disease CTD_human Familial tumoral calcinosis is characterized by ectopic calcifications and hyperphosphatemia due to inactivating mutations in FGF23 or UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3). 17710231 2007
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 Biomarker disease BEFREE Our understanding of FGF23 will help to develop novel therapies for phosphate wasting disorders, as well as for disorders of increased serum phosphate, such as tumoral calcinosis, a rare disorder, and renal failure, a common disorder. 15863037 2005
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 Biomarker disease BEFREE Impaired O-glycosylation of FGF23 due to the lack of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyl-transferase 3 (GALNT3) or due to certain homozygous FGF23 mutations results in reduced secretion of intact FGF23 and leads to familial hyperphosphatemic tumoral calcinosis. 22396161 2012
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 Biomarker disease BEFREE Thus, this report describes the first case, to our knowledge, of autoimmune hyperphosphatemic tumoral calcinosis with pathogenic autoantibodies targeting FGF23. 30226830 2018
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 AlteredExpression disease BEFREE Recent investigations indicate that excess actions of FGF23 cause several hypophosphatemic diseases whereas deficient FGF23 activity results in hyperphosphatemic tumoral calcinosis. 17276744 2007
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 GeneticVariation disease BEFREE In summary, we report a novel TC mutation and demonstrate a common defect of reduced FGF23 stability for all known FGF23-TC mutants. 18682534 2008
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 GeneticVariation disease BEFREE Familial tumoral calcinosis (TC), characterized by ectopic calcifications and hyperphosphatemia, is caused by mutations in the GALNT3 or fibroblast growth factor 23 (FGF23) genes. 17311862 2007
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 GeneticVariation disease BEFREE Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis. 19837926 2009
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.400 GeneticVariation disease BEFREE Serum matrix extracellular phosphoglycoprotein levels, however, were normal in the family with GALNT3-TC and a kindred with TC carrying the FGF23 S71G mutation. 16868048 2006